8-Bromo-3-methyl-xanthine CAS: 93703-24-3

Tsim los ntawm cov txheej txheem organic tshwj xeeb, 8-bromo-3-methyl-xanthine muaj cov qauv molecular sib txawv uas tseem ceeb rau nws cov ntawv thov ntau yam. Lub xanthine framework, hloov kho los ntawm bromine thiab methyl pawg, cuam tshuam rau nws cov tshuaj reactivity, solubility, thiab kev sib cuam tshuam nrog cov kab ke hauv lub cev. Cov yam ntxwv ntawm cov qauv no yog qhov tseem ceeb rau kev nkag siab txog nws cov ntaub ntawv pharmacological thiab lub peev xwm kho mob. Cov ntawv thov hauv Pharmaceuticals Cov tshuaj no muaj kev cia siab hauv kev tshawb fawb txog tshuaj vim nws cov qauv sib xyaw. Xanthine derivatives paub txog lawv cov haujlwm pharmacological ntau yam, suav nrog phosphodiesterase inhibitors thiab adenosine receptor antagonists. Kev sib xyaw ua ke ntawm bromine thiab methyl pawg ntawm 8-bromo-3-methyl-xanthine tuaj yeem txhim kho nws cov haujlwm biological thiab cuam tshuam rau nws txoj kev ua haujlwm, ua rau nws yog tus neeg sib tw rau kev tsim tshuaj yav tom ntej tsom mus rau ntau yam kab mob. Kev Ua Haujlwm Biological thiab Mechanisms Kev tshawb fawb qhia tias xanthine derivatives cuam tshuam nrog cov hom phiaj biological los ntawm cov txheej txheem xws li enzyme modulation thiab receptor binding. Cov kev hloov pauv bromine thiab methyl ntawm 8-bromo-3-methyl-xanthine tuaj yeem cuam tshuam nws lub zog, kev ruaj khov ntawm cov metabolism, thiab cov khoom pharmacokinetic, cuam tshuam rau nws cov txiaj ntsig thiab kev nyab xeeb hauv kev siv kho mob. Kev nkag siab txog cov txheej txheem no yog qhov tseem ceeb rau kev ua kom zoo dua nws lub peev xwm kho mob. Cov Kev Tsim Khoom thiab Kev Txhim Kho Kev tsim cov 8-bromo-3-methyl-xanthine cuam tshuam nrog cov txheej txheem organic nyuaj pib los ntawm cov neeg sawv cev xanthine thiab bromo-methylating. Kev ua kom zoo dua ntawm cov kev tsim khoom yog qhov tseem ceeb rau kev ua tiav cov khoom huv siab thiab cov txiaj ntsig, tseem ceeb rau kev tsim khoom lag luam thiab kev siv tshuaj. Kev kho cov txheej txheem tsim khoom kuj tseem ua rau muaj kev siv nyiaj ntau thiab kev ruaj khov hauv kev tshawb pom tshuaj thiab kev txhim kho. Kev Tshawb Fawb Tam Sim No thiab Cov Lus Qhia Yav Tom Ntej Cov kev siv zog tshawb fawb tam sim no tsom mus rau kev tshawb nrhiav cov tshuaj lom neeg ua haujlwm, suav nrog nws lub peev xwm ua tus neeg sawv cev tiv thaiv kev o lossis nws cov txiaj ntsig hauv kev kho mob neuroprotective. Cov kev tshawb fawb yav tom ntej yuav tshawb nrhiav cov kev hloov pauv qauv los txhim kho nws cov ntaub ntawv pharmacokinetic lossis txhim kho qhov tshwj xeeb rau cov hom phiaj kab mob tshwj xeeb. Ntxiv mus, kev tshawb fawb txuas ntxiv mus tsom mus rau kev lees paub nws qhov kev nyab xeeb thiab kev ua tau zoo los ntawm kev ntsuam xyuas preclinical thiab kev soj ntsuam hauv tsev kho mob. Xaus Lus Xaus Lus, 8-bromo-3-methyl-xanthine sawv cev rau ib qho tshuaj tseem ceeb hauv kev tshawb fawb txog tshuaj thiab kev tshawb fawb txog tshuaj vim nws cov qauv tshuaj sib txawv thiab cov peev xwm siv tau rau kev kho mob. Nws txoj kev koom ua ke ntawm bromine thiab methyl pawg rau hauv ib lub xanthine framework qhia txog nws cov lus cog tseg pharmacological thiab versatility. Kev txhim kho peb txoj kev nkag siab txog nws cov cwj pwm tshuaj, kev sib cuam tshuam ntawm cov kab mob, thiab cov txheej txheem tsim khoom yog qhov tseem ceeb rau kev siv nws lub peev xwm kho mob tag nrho thiab txhim kho nws cov ntawv thov hauv kev kho mob thiab cov teb cuam tshuam.